reporting season

Rumours of a private equity takeover were the story of 2022 for this company. What will 2023 bring?

The travel industry is benefitting from pent up travel demand. But that demand could be threatened if the global slowdown worsens.

Despite recording 20% revenue growth, and a massive cash position, it was a memorandum of understanding that has investors excited for CXL.

Bruce Williams from Elston Asset Management unpacks Santos' results and explains why it is in the Elston Australian Large Companies Fund.

This company is burning cash ahead of a final investment decision around the commencement of a globally significant rare earths project.

Revenues and profits are soaring at this company. It's acquired two stateside rivals. And it's expecting the good times to keep rolling.

Australia’s supermarket duopoly has had strong half-year earnings, and this could be their time to shine.

There's a lot to like about gold but not all gold miners are made equal.

Ratings, consensus price targets, and FNArena insights on each stock covered feature in the following article

Whilst revenue and profit were down from last year, this miner beat expectations by 14% and added $50m to its current buyback.

Investors rejoiced when Telstra hiked its dividend for the first time in seven years at its full-year result. But will the payouts continue?

Management says this company is in a strong position, but the health of the company is not the same thing as the value of its stock.

Shrinking margins and rising costs overshadow what was otherwise a positive half-yearly result for the retail and industrial conglomerate

The rising rates environment has benefited the banks, although Commbank's report may indicate that NIM expansion is coming to an end.

In this video I joined Scott Phillips to provide an update on what we have seen from reporting season so far. It is early in the number of companies who have reported,...

One of Australia's premier mid-caps has handed down its first-half results. But has it managed to surprise the market yet again?

Antares’ Andrew Hamilton believes the market is missing some key drivers for the global leader in hearing implants.

Australia’s healthcare darling delivered solid results and continued to outflank its competitors on Tuesday.

This building materials company shows why cost advantage is the name of the game.

If someone had said that 2023 would see the strongest start to a trading year in over 20 years, you would have laughed. If someone then said the ASX Accumulation Index...